Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities

NCT04572893 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Primary Familial Dilated Cardiomyopathy

Interventions

DRUG: danicamtiv

Sponsor

Bristol-Myers Squibb